STOCK ALARM
PRO
SA
PRO
Market
Screener
Charts
Alerts
⌘
K
LON
NYC
Crypto
Pro
Sign In
Free Account
Cidara Therapeutics, Inc.
CDTX
NASDAQ
LOADING
|
|
|
Overview
Charts
News
Fundamentals
Key Metrics
TTM
Financials
Earnings
Growth
Rating
Analysts
Institutional
Peers
Historical
Key Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
As of
2024
• vs 2023
Annual
Quarterly
Per Share
Revenue/Share
$0.20
-96.2%
Net Income/Share
$-26.75
-409.9%
Operating CF/Share
$-27.80
-441.8%
Free CF/Share
$-27.82
-430.2%
Cash/Share
$29.90
+265.3%
Book Value/Share
$25.72
+1469.4%
Tangible Book/Share
$25.72
+1469.4%
Equity/Share
$25.72
+1469.4%
Interest Debt/Share
$0.56
-49.5%
Valuation
Market Cap
$170.68M
+145.9%
Enterprise Value
-$15.57M
-140.4%
P/E Ratio
-1.01
+66.8%
P/S Ratio
133.87
+4389.9%
P/OCF Ratio
-0.97
+68.8%
P/FCF Ratio
-0.97
+68.1%
P/B Ratio
1.05
+112.4%
P/TB Ratio
1.05
+112.4%
EV/Sales
-12.21
-838.2%
EV/EBITDA
0.09
+106.2%
Profitability
Earnings Yield
-99.50%
-201.2%
FCF Yield
-103.51%
-213.3%
ROE
-103.99%
-137.2%
ROIC
-105.52%
+96.4%
Return on Tangible Assets
-79.06%
-131.1%
Capital Allocation
CapEx/OCF
-0.07%
+96.8%
CapEx/Revenue
10.12%
+366.5%
CapEx/Depreciation
0.55
-87.1%
SBC/Revenue
306.43%
+2230.8%
Balance Sheet
Debt/Equity
0.02
+103.7%
Debt/Assets
0.02
-77.1%
Net Debt/EBITDA
1.06
-7.6%
Current Ratio
4.25
+371.1%
Interest Coverage
0.00x
Income Quality
1.04
+6.3%
Efficiency
Days Sales Outstanding
485 days
+90.4%
Days Payables Outstanding
0 days
Days Inventory
0 days
Receivables Turnover
0.75x
-47.5%
Payables Turnover
0.00x
Inventory Turnover
0.00x
Special Valuations
Graham Number
--
Graham Net-Net
$21.99
+496.7%